Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Replicating viruses as selective cancer therapeutics

D H Kirn1, F McCormick

  • 1Director of Pre-clinical and Clinical Research, ONYX Pharmaceuticals, Richmond, CA 94806, USA.

Molecular Medicine Today
|December 1, 1996
PubMed
Summary

Replication-competent viruses show promise as cancer therapies, with research clarifying tumor-specific replication and effectiveness. Various viruses are under development, alongside studies on antiviral immunology and overcoming immune defenses.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Workload for infection prevention and control teams in preventing nosocomial tuberculosis: an underestimated burden.

The Journal of hospital infection·2022
Same author

Ancient DNA, lipid biomarkers and palaeoecological evidence reveals construction and life on early medieval lake settlements.

Scientific reports·2021
Same author

Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE).

Oncoimmunology·2019
Same author

Family-focused practice within a recovery framework: practitioners' qualitative perspectives.

BMC health services research·2017
Same author

In-hospital mortality risk of intertrochanteric hip fractures: a comprehensive review of the US Medicare database from 2005 to 2010.

Musculoskeletal surgery·2017
Same author

ABO-Incompatible Kidney Transplants: Twice as Expensive, Half as Good.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015

Area of Science:

  • Oncolytic virotherapy
  • Cancer immunology

Background:

  • Replication-competent viruses are emerging as targeted cancer therapeutics.
  • Understanding tumor-specific viral replication and efficacy is crucial.

Purpose of the Study:

  • To review the mechanisms of tumor-specific viral replication and antitumoral efficacy.
  • To highlight viruses currently in development for cancer therapy.
  • To discuss antiviral immunology and host defenses in this context.

Main Methods:

  • Review of current literature on oncolytic viruses.
  • Analysis of viral mechanisms for tumor targeting and replication.
  • Examination of immunological responses to viral cancer therapy.

Main Results:

Related Experiment Videos

  • Mechanisms for tumor-specific viral replication and efficacy are becoming clearer.
  • Several virus types are in development, including herpes simplex viruses, parvoviruses, Newcastle disease viruses, and adenoviruses.
  • Insights into antiviral immunology and host immune evasion strategies are available.

Conclusions:

  • Oncolytic virotherapy holds significant therapeutic potential for cancer treatment.
  • Further research is needed to overcome existing hurdles for clinical application.